| 4.23 MDM2 Promotor Polymorphism and Disease Characteristics in CLL: Individual Patient Data Meta-Analysis of 2598 CLL Patients A Benner, L Mansouri, D Rossi, A Majid, K Willander, A Parker, G Bond, ... Clinical Lymphoma, Myeloma and Leukemia 11, S233-S235, 2011 | | 2011 |
| A chromatin-associated and transcriptionally inactive p53-Mdm2 complex occurs in mdm2 SNP309 homozygous cells NC Arva, TR Gopen, KE Talbott, LE Campbell, A Chicas, DE White, ... Journal of Biological Chemistry 280 (29), 26776-26787, 2005 | 152 | 2005 |
| A common polymorphism in the retinoic acid pathway modifies adrenocortical carcinoma age-dependent incidence M Surakhy, M Wallace, E Bond, LF Grochola, H Perez, ... British journal of cancer 122 (8), 1231-1241, 2020 | 11 | 2020 |
| A genetic model for central chondrosarcoma evolution correlates with patient outcome W Cross, I Lyskjær, T Lesluyes, S Hargreaves, AC Strobl, C Davies, ... Genome medicine 14 (1), 99, 2022 | 10 | 2022 |
| A genetic variant in a PP2A regulatory subunit encoded by the PPP2R2B gene associates with altered breast cancer risk and recurrence A Vazquez, D Kulkarni, LF Grochola, GL Bond, N Barnard, D Toppmeyer, ... International journal of cancer 128 (10), 2335-2343, 2011 | 32 | 2011 |
| A genome-wide screen for functional inherited high-frequency genetic variants that affect survival of resectable pancreatic ductal adenocarcinoma. LF Grochola, C Dimitrakopoulos, Vrugt, R Flury, U Knippschild, R Graf, ... SWISS MEDICAL WEEKLY 148, 10S-10S, 2018 | | 2018 |
| A genome-wide screen for inherited genetic variants that affect survival and therapy of resectable pancreatic ductal adenocarcinoma C Dimitrakopoulos, B Vrugt, R Flury, U Knippschild, D Henne-Bruns, ... HPB 20, S559, 2018 | | 2018 |
| A high-frequency human genetic variant in the CD44 gene affects survival of ductal adenocarcinoma of the pancreas LF Grochola, GL Bond, R Graf, B Vrugt, PA Clavien, P Schraml, ... BRITISH JOURNAL OF SURGERY 102, 7-7, 2015 | | 2015 |
| A high-frequency regulatory polymorphism in the p53 pathway accelerates tumor development SM Post, A Quintás-Cardama, V Pant, T Iwakuma, A Hamir, JG Jackson, ... Cancer cell 18 (3), 220-230, 2010 | 122 | 2010 |
| A novel map of human p53 response elements uncovers evidence of selection pressures and variants similar to Li-Fraumeni Syndrome mutations P Zhang, K Brown, D Barnes, I Kitchen-Smith, D Sims, A Flanagan, ... medRxiv, 2022.09. 28.22280453, 2022 | | 2022 |
| A polymorphic antioxidant response element links NRF2/sMAF binding to enhanced MAPT expression and reduced risk of Parkinsonian disorders X Wang, MR Campbell, SE Lacher, HY Cho, M Wan, CL Crowl, ... Cell reports 15 (4), 830-842, 2016 | 48 | 2016 |
| A polymorphic enhancer near GREM1 influences bowel cancer risk through differential CDX2 and TCF7L2 binding A Lewis, L Freeman-Mills, E de la Calle-Mustienes, RM Giráldez-Pérez, ... Cell reports 8 (4), 983-990, 2014 | 54 | 2014 |
| A polymorphic p53 response element in KIT ligand influences cancer risk and has undergone natural selection J Zeron-Medina, X Wang, E Repapi, MR Campbell, D Su, F Castro-Giner, ... Cell 155 (2), 410-422, 2013 | 133 | 2013 |
| A RASSF1A polymorphism restricts p53/p73 activation and associates with poor survival and accelerated age of onset of soft tissue sarcoma KS Yee, L Grochola, G Hamilton, A Grawenda, EE Bond, H Taubert, ... Cancer research 72 (9), 2206-2217, 2012 | 46 | 2012 |
| A single nucleotide polymorphism in the CD44 gene affects survival of pancreatic ductal adenocarcinoma LF Grochola, G Stracquadanio, R Graf, B Vrugt, S Breitenstein, P Schraml, ... HPB 18, e422, 2016 | | 2016 |
| A single nucleotide polymorphism in the HDM-2 gene regulates the p53 apoptotic response and influences the age of onset of cancers in humans: the SNP 309 HDM-2 polymorphism GL Bond, AJ Levine Breast Cancer Research 7 (Suppl 2), S. 30, 2005 | | 2005 |
| A single nucleotide polymorphism in the HDM-2 gene regulates the p53 apoptotic response and influences the age of onset of cancers in humans. A Levine, G Bond | | 2005 |
| A single nucleotide polymorphism in the MDM2 gene: from a molecular and cellular explanation to clinical effect GL Bond, W Hu, A Levine Cancer research 65 (13), 5481-5484, 2005 | 242 | 2005 |
| A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans GL Bond, W Hu, EE Bond, H Robins, SG Lutzker, NC Arva, J Bargonetti, ... Cell 119 (5), 591-602, 2004 | 1489 | 2004 |
| A single nucleotide polymorphism in the p53 pathway interacts with gender, environmental stresses and tumor genetics to influence cancer in humans GL Bond, AJ Levine Oncogene 26 (9), 1317-1323, 2007 | 216 | 2007 |
